                         SEQUENCE LISTING

<110>  THE GENERAL HOSPTIAL CORPORATION
       PRESIDENT AND FELLOWS OF HARVARD COLLEGE
       DANA-FARBER CANCER INSTITUTE, INC.
 
<120>  COMPOUNDS AND METHODS OF THEIR USE

<130>  51319-002WO2

<140>  PCT/US19/56318
<141>  2019-10-15

<150>  62/745,122
<151>  2018-10-12

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  1

Gly Pro Cys Asp Leu Asp Ala Ala Leu Leu Thr Asp Ile Glu Asp Met 
1               5                   10                  15      


Leu Asn Leu Ile Asn Asn Gln Asp Ser Asp 
            20                  25      


<210>  2
<211>  19
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  2
ccaagctgtc agcccatgt                                                    19


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  3
cgtctctctg gctccctcta                                                   20


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  4
ggcagaggga acagcagatt                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  5
ggcttctgta aactccggct                                                   20


<210>  6
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  6
tcgaacggct attggttggc                                                   20


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Construct

<400>  7
acgaacggtc gccttaacaa                                                   20


